Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

Treatments for gestational diabetes: a systematic review and meta-analysis

Open access

Abstract

Objective: To investigate the effectiveness of different treatments for gestational diabetes mellitus (GDM). Design: Systematic review, meta-analysis and network meta-analysis. Methods: Data sources were searched up to July 2016 and included MEDLINE and Embase. Randomised trials comparing treatments for GDM (packages of care (dietary and lifestyle interventions with pharmacological treatments as required), insulin, metformin, glibenclamide (glyburide)) were selected by two authors and double checked for accuracy. Outcomes included large for gestational age, shoulder dystocia, neonatal hypoglycaemia, caesarean section and pre-eclampsia. We pooled data using random-effects meta-analyses and used Bayesian network meta-analysis to compare pharmacological treatments (ie, including treatments not directly compared within a trial). Results: Forty-two trials were included, the reporting of which was generally poor with unclear or high risk of bias. Packages of care varied in their composition and reduced the risk of most adverse perinatal outcomes compared with routine care (eg, large for gestational age: relative risk0.58 (95% CI 0.49 to 0.68; I 2 =0%; trials 8; participants 3462). Network meta-analyses suggest that metformin had the highest probability of being the most effective treatment in reducing the risk of most outcomes compared with insulin or glibenclamide. Conclusions: Evidence shows that packages of care are effective in reducing the risk of most adverse perinatal outcomes. However, trials often include few women, are poorly reported with unclear or high risk of bias and report few outcomes. The contribution of each treatment within the packages of care remains unclear. Large well-designed and well-conducted trials are urgently needed. Trial registration number: PROSPERO CRD42013004608.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2016-015557

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Search process.
Figure 1 Search process.CC BY · PubMed Central
Figure 2 Forest plots for treatment comparisons and perinatal outcomes. (A) Packages of care (starting with dietary modification) versus routine care: dichotomous outcomes. (B) Packages of care (starting with dietary modification) versus routine care: continuous outcomes. (C) Metformin versus insulin: dichotomous outcomes. (D) Metformin versus insulin: continuous outcomes. (E) Glibenclamide versus insulin: dichotomous outcomes. (F) Glibenclamide versus insulin: continuous outcomes. (G) Glibenclamide versus metformin: dichotomous outcomes. (H) Glibenclamide versus metformin: continuous outcomes.
Figure 2 Forest plots for treatment comparisons and perinatal outcomes. (A) Packages of care (starting with dietary modification) versus routine care: dichotomous outcomes. (B) Packages of care (starting with dietary modification) versus routine care: continuous outcomes. (C) Metformin versus insulin: dichotomous outcomes. (D) Metformin versus insulin: continuous outcomes. (E) Glibenclamide versus insulin: dichotomous outcomes. (F) Glibenclamide versus insulin: continuous outcomes. (G) Glibenclamide versus metformin: dichotomous outcomes. (H) Glibenclamide versus metformin: continuous outcomes.CC BY · PubMed Central
Figure 3 Network meta-analysis, relationship of treatment comparisons.
Figure 3 Network meta-analysis, relationship of treatment comparisons.CC BY · PubMed Central
Figure 4 Network meta-analysis comparing metformin, glibenclamide and insulin. First better, treatment listed first in the outcome column is superior; second better, treatment listed second in the outcome column is superior. C-section, caesarean section; LGA, large for gestational age; NICU, neonatal intensive care unit.
Figure 4 Network meta-analysis comparing metformin, glibenclamide and insulin. First better, treatment listed first in the outcome column is superior; second better, treatment listed second in the outcome column is superior. C-section, caesarean section; LGA, large for gestational age; NICU, neonatal intensive care unit.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 83 references

Research works printed but not linked: 4

  1. Centre for Reviews and Dissemination. Systematic reviews: CRD's guidance for undertaking a systematic review York: CRD, University of York, 2009.
  2. Zinnat, 2013, Can metformin be used in place of insulin for the treatment of GDM for low resource countries?, BJOG, 120, 35
  3. 10.1111/j.1471-0528.2010.02763.x · DOI · Paper page
  4. O’Sullivan, 1967, Diabetes, 13, 278

Cited by

See all 169

Metadata

Authors
Farrar, D., Simmonds, M., Bryant, M., Sheldon, T. A., Tuffnell, D., Golder, S., & Lawlor, D. A.
Affiliations
  • Bradford Royal Infirmary (GB)
  • University of York (GB)
  • University of Leeds (GB)
  • Bradford Teaching Hospitals NHS Foundation Trust (GB)
  • University of Bristol (GB)
Corresponding author
Farrar, Diane
Venue
BMJ Open
Publisher
BMJ
Published
2017-06
Volume
7
Issue
6
Pages
e015557
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2626502458
Cited by
163
References
83
Citations by year
2026: 6 · 2025: 18 · 2024: 17 · 2023: 22 · 2022: 22 · 2021: 26 · 2020: 17 · 2019: 16 · 2018: 16 · 2017: 2
FWCI
2.39
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMJ Open (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Explore Bristol Research (publishedVersion, cc-by)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion, public-domain)
  • HighWire Press Open Archive (submittedVersion)
  • Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
  • Bristol Research (University of Bristol) (submittedVersion, cc-by)
Funders
Health Technology Assessment Programme
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, treatment effectiveness, insulin therapy, metformin, glibenclamide, dietary and lifestyle interventions, perinatal outcomes, large for gestational age, shoulder dystocia, neonatal hypoglycemia, cesarean section, preeclampsia
MeSH terms
Bayes Theorem, Cesarean Section, Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy, Pregnancy Outcome, Randomized Controlled Trials as Topic, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatments for gestational diabetes: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1136/bmjopen-2016-015557
The paper
Farrar, D., Simmonds, M., Bryant, M., Sheldon, T. A., Tuffnell, D., Golder, S., & Lawlor, D. A. (2017). Treatments for gestational diabetes: a systematic review and meta-analysis. BMJ Open. https://doi.org/10.1136/bmjopen-2016-015557

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.